SwePub
Sök i LIBRIS databas

  Extended search

WFRF:(Åhs Fredrik)
 

Search: WFRF:(Åhs Fredrik) > (2010-2014) > Amygdala-frontal co...

Amygdala-frontal couplings characterizing SSRI and placebo response in social anxiety disorder

Faria, Vanda (author)
Uppsala universitet,Institutionen för psykologi
Åhs, Fredrik (author)
Uppsala universitet,Karolinska Institutet,Institutionen för psykologi,Department of Psychology and Neuroscience, Duke University, Durham, NC, USA
Appel, Lieuwe (author)
Uppsala universitet,Enheten för nuklearmedicin och PET
show more...
Linnman, Clas (author)
P.A.I.N. Group, Department of Anesthesia, Children's Hospital, Boston, MA, USA
Bani, Massimo (author)
GlaxoSmithKline, Medicine Research Centre, Verona, Italy
Bettica, Paolo (author)
GlaxoSmithKline, Medicine Research Centre, Verona, Italy
Pich, Emilio Merlo (author)
GlaxoSmithKline, Medicine Research Centre, Verona, Italy
Fredrikson, Mats (author)
Uppsala universitet,Institutionen för psykologi
Furmark, Tomas (author)
Uppsala universitet,Institutionen för psykologi
show less...
 (creator_code:org_t)
Oxford University Press, 2014
2014
English.
In: International Journal of Neuropsychopharmacology. - : Oxford University Press. - 1461-1457 .- 1469-5111. ; 17:8, s. 1149-57
  • Journal article (peer-reviewed)
Abstract Subject headings
Close  
  • UNLABELLED: In patients with social anxiety disorder (SAD) it has been reported that selective serotonin reuptake inhibitors (SSRIs) and placebo induce anxiolytic effects by attenuating neural activity in overlapping amygdala subregions, i.e. left basolateral and right ventrolateral amygdala. However, it is not known whether these treatments inhibit amygdala subregions via similar or distinct brain pathways. As anxiolytic treatments may alter amygdala-frontal couplings we investigated differences and similarities in amygdala-frontal functional co-activation patterns between responders and nonresponders to SSRIs and placebo in patients with SAD. Positron emission tomography (PET) with oxygen-15-labeled water was used to measure anxiety-related regional cerebral blood flow in 72 patients with SAD before and after 6-8 wk of treatment under double-blind conditions. Functional couplings were evaluated with a seed region approach using voxel values from the left basolateral and right ventrolateral amygdala. Responders and nonresponders to SSRIs and placebo showed different treatment-induced co-activations between the left amygdala and the dorsolateral prefrontal cortex (dlPFC) as well as the rostral anterior cingulate cortex (ACC). Conjunction analysis suggested shared anxiolysis-dependent inverse co-activations in SSRI and placebo responders between the left amygdala-dlPFC and left amygdala-rostral ACC, and a shared positive co-activation between left amygdala-dorsal ACC. We demonstrate that amygdala-frontal co-activation patterns differentiate effective from ineffective anxiolytic treatments and that SSRI and placebo responders share overlapping neuromodulatory paths that may underlie improved emotion regulation and reduced expression of anxiety.TRIAL REGISTRATION: clinicaltrials.gov Identifier: NCT00343707.

Subject headings

MEDICIN OCH HÄLSOVETENSKAP  -- Medicinska och farmaceutiska grundvetenskaper -- Neurovetenskaper (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Basic Medicine -- Neurosciences (hsv//eng)
SAMHÄLLSVETENSKAP  -- Psykologi (hsv//swe)
SOCIAL SCIENCES  -- Psychology (hsv//eng)

Keyword

Amygdala
anxiety
dlPFC
placebo
rACC
SSRI
Neuroscience

Publication and Content Type

ref (subject category)
art (subject category)

Find in a library

To the university's database

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view